Pholcodine is an opioid-derived antitussive (cough suppressant) developed in the mid-20th century and widely used in many countries for the relief of dry, non-productive cough. It acts primarily on the central nervous system by suppressing the cough reflex in the medullary cough center without producing strong analgesic or euphoric effects like other opioids. Pholcodine has been used in various over-the-counter and prescription cough preparations, although its use has been restricted or withdrawn in some regions due to concerns about potential links with anaphylactic reactions to neuromuscular blocking agents used in anesthesia.
BRAND NAMES
Pholtex An effervescent tablet containing 200mg of N-Acetylcysteine
Pholcodine Linctus (common generic label used in many countries)
Tusscodine a combination medication used to treat dry coughs
Codinol a combination medication used to treat dry cough
Beechams Pholcodine Linctus (in some formulations)
MECHANISM OF ACTION
Pholcodine is a centrally acting antitussive (cough suppressant) that works primarily by depressing the cough center in the medulla of the brainstem. It reduces the sensitivity of the cough reflex without producing significant analgesic or strong opioid effects. Unlike classic opioids, pholcodine has minimal activity at peripheral opioid receptors and a relatively low risk of respiratory depression at therapeutic doses.
PHARMACOKINETICS
Absorption
Pholcodine is well absorbed from the gastrointestinal tract after oral administration. It has a relatively slow onset of action, with peak plasma levels occurring within a few hours. Food does not significantly affect its absorption.
Distribution
Pholcodine is widely distributed in body tissues and crosses the blood–brain barrier to exert its central effects. It has low to moderate plasma protein binding.
Metabolism
The drug is slowly metabolized in the liver, mainly through hepatic pathways. It has a long duration of action due to its slow metabolism and prolonged presence in the body.
Elimination
Pholcodine and its metabolites are excreted primarily through the kidneys in urine. It has a long elimination half-life, contributing to prolonged antitussive effects.
PHARMACODYNAMICS
Pholcodine acts on the central nervous system to suppress the cough reflex by reducing the responsiveness of the medullary cough center. It has weak opioid receptor activity, which provides antitussive effects without significant analgesia, sedation, or euphoria. Its action helps reduce dry, non-productive cough without affecting mucus clearance significantly.
ADMINISTRATION
Pholcodine is administered orally as syrups, linctuses, or tablets. It is used for the symptomatic relief of dry or irritating cough and is typically taken every 6–8 hours depending on formulation.
DOSAGE AND STRENGTH
Adult doses commonly range from 5–15 mg per dose, up to 3–4 times daily, depending on the preparation. Pediatric dosing is lower and based on age and formulation. Duration of use is usually short-term.
DRUG INTERACTIONS
Pholcodine may enhance the sedative effects of alcohol, antihistamines, benzodiazepines, and other CNS depressants, increasing drowsiness and impairment. Caution is advised when combined with other opioid or sedating medications.
FOOD INTERACTIONS
There are no major food interactions, but alcohol should be avoided as it may increase sedation and CNS depression.
CONTRAINDICATIONS
Pholcodine is contraindicated in patients with hypersensitivity to opioids, and should be used cautiously in individuals with respiratory depression, chronic bronchitis, or severe asthma.
SIDE EFFECTS
Common side effects include drowsiness, dizziness, nausea, constipation, and mild stomach discomfort. Rarely, allergic reactions or respiratory depression may occur at high doses.
OVER DOSAGE
Pholcodine overdose is uncommon but can lead to central nervous system and respiratory depression. Early symptoms may include excessive drowsiness, dizziness, confusion, nausea, and vomiting. In more severe cases, patients may develop marked sedation, loss of consciousness, and slowed or shallow breathing (respiratory depression).
TOXICITY
Pholcodine overdose may cause severe drowsiness, confusion, nausea, vomiting, and respiratory depression in extreme cases. Management is mainly supportive, including airway protection and monitoring of respiratory function. In significant overdose, naloxone may be considered as an opioid antagonist, although pholcodine has relatively weak opioid activity compared to other opioids.
